Article
An Update on Treatment Options and Pipeline Developments for Type 2 Diabetes
IQVIA Pipeline Intelligence
Feb 02, 2023

The International Diabetes Federation (IDF) has estimated that diabetes affects approximately 537 million adults aged 20 to 79 years worldwide and is projected to rise to 643 and 783 million by 2030 and 2045, respectively. Type 2 diabetes is the prevalent form of diabetes and accounts for approximately 90% to 95% of all diabetes cases in the USA and the UK. According to the IDF, the disease imposes a global annual economic burden of USD 966 billion in associated healthcare costs. This article will provide an update on current treatment options for type 2 diabetes and outline the latest development activities of key experimental drugs with data sourced from IQVIA Pipeline Intelligence, a proprietary drug pipeline database.

Please fill in your details on the left, to download the article.

Related solutions

Contact Us